- Home
- UPLD vs XGN Comparison
UPLD vs XGN Comparison
Compare UPLD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- XGN
- Stock Information
- Founded
- UPLD 2010
- XGN 2002
- Country
- UPLD United States
- XGN United States
- Employees
- UPLD N/A
- XGN N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- XGN Medical Specialities
- Sector
- UPLD Technology
- XGN Health Care
- Exchange
- UPLD Nasdaq
- XGN Nasdaq
- Market Cap
- UPLD 70.5M
- XGN 138.3M
- IPO Year
- UPLD 2014
- XGN 2019
- Fundamental
- Price
- UPLD $2.57
- XGN $9.16
- Analyst Decision
- UPLD Strong Buy
- XGN Strong Buy
- Analyst Count
- UPLD 1
- XGN 5
- Target Price
- UPLD $4.50
- XGN $12.40
- AVG Volume (30 Days)
- UPLD 893.4K
- XGN 210.4K
- Earning Date
- UPLD 11-06-2025
- XGN 11-11-2025
- Dividend Yield
- UPLD N/A
- XGN N/A
- EPS Growth
- UPLD N/A
- XGN N/A
- EPS
- UPLD N/A
- XGN N/A
- Revenue
- UPLD $251,757,000.00
- XGN $58,862,000.00
- Revenue This Year
- UPLD N/A
- XGN $22.09
- Revenue Next Year
- UPLD N/A
- XGN $13.62
- P/E Ratio
- UPLD N/A
- XGN N/A
- Revenue Growth
- UPLD N/A
- XGN 3.89
- 52 Week Low
- UPLD $1.69
- XGN $2.38
- 52 Week High
- UPLD $5.64
- XGN $10.34
- Technical
- Relative Strength Index (RSI)
- UPLD 50.01
- XGN 44.93
- Support Level
- UPLD $2.29
- XGN $9.55
- Resistance Level
- UPLD $2.59
- XGN $10.28
- Average True Range (ATR)
- UPLD 0.21
- XGN 0.40
- MACD
- UPLD -0.04
- XGN -0.13
- Stochastic Oscillator
- UPLD 20.27
- XGN 4.66
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.